BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04284787-completion@plaintrial.com
DTSTAMP:20261028T002212Z
DTSTART;VALUE=DATE:20270130
SUMMARY:BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Targ
 et Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized P
 hase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine an
 d Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leu
 kemia — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04284787
URL:https://plaintrial.com/trial/NCT04284787
END:VEVENT
END:VCALENDAR